SEC Form 4 · accession 0001610950-17-000052
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher L Gaenzle
Officer — CAO, GC & Sec
Period of report
Sep 15, 2017
Accepted (ET)
Sep 19, 2017 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 15, 2017 | F | 4,245 | $54.85 | D | 60,579 | D | |
| Class A Common StockF2 | Sep 18, 2017 | S | 4,682 | $54.555 | D | 55,897 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 3, 2017.
- F2The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.20 to $54.85, inclusive. The reporting person will provide to INC Research Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.